Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Maintains Sell Rating on First Industrial Realty with Revised Price Target

Elaine Mendonca by Elaine Mendonca
January 11, 2024
in Breaking News
0
Finance_Capitalization
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 11, 2024, Caitlin Burrows, an analyst at Goldman Sachs, expressed her bearish sentiment towards First Industrial Realty (NYSE:FR) by maintaining a Sell rating on the stock. However, she did revise the price target from $41 to $47, suggesting that she believes the stock should be sold at a higher price than previously anticipated.

Burrows’ recommendation to sell the stock is rooted in her thorough evaluation of First Industrial Realty’s performance and the prevailing market conditions. This implies that Goldman Sachs is cautioning investors about the stock’s potential downside and advising them to consider divesting their holdings in light of the company’s current situation and the overall market dynamics.

[bs_slider_forecast ticker=”FR”]

FR Stock Performance on January 11, 2024: Mixed Performance and Potential Decline

FR Stock Performance on January 11, 2024:

On January 11, 2024, FR stock displayed a mixed performance, with some notable indicators suggesting a potential decline in its value. FR was trading near the top of its 52-week range, indicating a relatively strong position within the market. The stock was also observed to be trading above its 200-day simple moving average, highlighting its positive momentum.

However, FR experienced a decrease in its share price since the previous market close. The price of FR shares dropped by $0.72, representing a decline of 1.35%. This decrease suggests a potential shift in investor sentiment towards the stock.

FR opened at $52.99 on January 11, 2024, which was $0.49 lower than its previous close. This opening price indicates a slight downward trend in the stock’s value.

Investors and analysts will likely closely monitor FR’s performance in the coming days to determine whether the decline in share price is indicative of a larger trend or merely a temporary setback.

It is important to note that stock market performance is influenced by factors such as market conditions, industry trends, company financials, and investor sentiment. Therefore, it is crucial to consider these factors and conduct thorough research before making any investment decisions.

In conclusion, FR stock displayed mixed performance on January 11, 2024. While the stock was trading near the top of its 52-week range and above its 200-day simple moving average, it experienced a decline in share price since the previous market close. Investors and analysts will likely closely monitor FR’s performance in the coming days to gain a better understanding of its trajectory and make informed investment decisions.

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”FR” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]

FR Stock Displays Strong Performance on January 11, 2024: Positive Trends in Revenue, Net Income, and EPS

On January 11, 2024, FR stock displayed strong performance, with positive indicators across various financial metrics. Total revenue for FR stood at $539.93 million over the past year, indicating a 13.36% increase compared to the previous year. Net income also showed a significant improvement for FR, reaching $358.79 million over the past year, representing a robust increase of 32.54% compared to the previous year. Earnings per share (EPS) stood at $2.72 over the past year, reflecting a notable increase of 30.21% compared to the previous year. Overall, FR stock showed strong performance on January 11, 2024, with positive trends across total revenue, net income, and earnings per share. Investors and market analysts may view these positive indicators as a sign of a well-performing company, potentially leading to increased investor confidence and demand for FR stock. However, it is essential to consider other factors such as market conditions, industry trends, and company-specific developments before making any investment decisions. Disclaimer: The information provided in this article is based on publicly available data from CNN Money. It is for informational purposes only and should not be considered as financial advice.

Tags: FR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Banking Trading online

Citigroups Financial Results for Q4 2023 and FullYear Revealed with Reserves and Charges

Real Estate Investment Trading online

COPT Defense Properties Exceeds Leasing Targets and Demonstrates Stability in HighSecurity Sectors

Biopharmaceutical Markets and money (1)

Assessing Novo Nordisks Valuation and Future Performance

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com